Kane Biotech(TSE:KNE)
CA$0.030.00 (0.00%)
TSE:KNE
Kane Biotech ownership
CA$0.03
At close:0.00 (0.00%)
Want to see TSE:KNE full AI Analyst Report?
Kane Biotech (KNE) Ownership - Who Owns Kane Biotech?
2 Followers
Kane Biotech (KNE) Ownership Overview
- 34.33% Insiders
- 65.67% Public Companies and Individual Investors
The ownership structure of Kane Biotech (TSE:KNE) stock is a mix of institutional, retail, and individual investors. , 34.33% is owned by Insiders, and 65.67% is owned by Public Companies and Individual Investors.
The ownership structure of Kane Biotech (TSE:KNE) stock is a mix of institutional, retail, and individual investors. , 34.33% is owned by Insiders, and 65.67% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| May 28, 2026 | Philip R Renaud | C$1,000,000 | |
| Dec 18, 2025 | Philip R Renaud | C$700,000 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Philip R Renaud | 70,389,711 | Insider | 34.33% | 1,478,184 |
FAQ
What percentage of Kane Biotech (TSE:KNE) stock is held by retail investors?
According to the latest TipRanks data, approximately 65.67% of Kane Biotech (TSE:KNE) stock is held by public companies and individual investors.
Who owns the most shares of Kane Biotech (TSE:KNE)?
Philip R Renaud owns the most shares of Kane Biotech (TSE:KNE).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

